Live from the NIH registry
Studies recruiting near Hagerstown right now
Top 25 of 111 recruiting studies, sorted by proximity — each links to its official registry page
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Wellspan Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Duke University
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
Locally Advanced Lung Non-Small Cell Carcinoma, Stage IIB Lung Cancer AJCC v8
Phase 3
Interventional 474 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Cataract
Phase 3
Interventional 528 participants sought
Maryland Vision Institute — Hagerstown, Maryland (0.1 mi)
· Sponsor: Melt Pharmaceuticals
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Carcinoma, Non-Small-Cell Lung
Phase 3
Interventional 700 participants sought
James M Stockman Cancer Institute — Frederick, Maryland (22.8 mi)
· Sponsor: Eli Lilly and Company
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Geographic Atrophy Secondary to Age-related Macular Degeneration
Phase 2
Interventional 240 participants sought
ADARx Clinical Site — Hagerstown, Maryland (0.1 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Cumberland Valley Retina Consultants,P.C. — Hagerstown, Maryland (0.1 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Cancer, Immunotherapy
N/A
Observational 2,000 participants sought
Frederick Health Hospital — Frederick, Maryland (22.8 mi)
· Sponsor: Elephas
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Carcinoma, Non-Small Cell Lung
Phase 3
Interventional 830 participants sought
Research Site — Frederick, Maryland (22.8 mi)
· Sponsor: AstraZeneca
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Cumberland Valley Retina Consultants (Site 007) — Hagerstown, Maryland (0.1 mi)
· Sponsor: EyeBiotech Ltd.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: Agendia
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
Frederick Oncology Hematology Associates — Frederick, Maryland (22.8 mi)
· Sponsor: City of Hope Medical Center
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
WellSpan Medical Oncology and Hematology — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: NRG Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Chambersburg Hospital — Chambersburg, Pennsylvania (20.8 mi)
· Sponsor: Novo Nordisk A/S
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Geographic Atrophy
Phase 1, Phase 2
Interventional 104 participants sought
Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003 — Hagerstown, Maryland (0.1 mi)
· Sponsor: Sanofi
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: NRG Oncology
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Breast Cancer
N/A
Observational 1,800 participants sought
Meritus Center for Clinical Research — Hagerstown, Maryland (0.1 mi)
· Sponsor: Exact Sciences Corporation
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
WVUH-Berkely Medical Center — Martinsburg, West Virginia (18.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
GEMINI-NSCLC: NSCLC Biomarker Study
Non-Small Cell Lung Cancer
N/A
Observational 1,200 participants sought
Frederick Health Regional System — Frederick, Maryland (22.8 mi)
· Sponsor: Tempus AI
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Geographic Atrophy of the Macula
Phase 2
Interventional 110 participants sought
Cumberland Valley Retina Consultants — Hagerstown, Maryland (0.1 mi)
· Sponsor: Galimedix Therapeutics Inc
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Irritable Bowel Syndrome
Phase 2
Interventional 95 participants sought
Frederick County Pediatrics /ID# 234519 — New Market, Maryland (30.0 mi)
· Sponsor: AbbVie
Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
Adolescent Alcohol Use
N/A
Interventional 1,500 participants sought
Johns Hopkins Community Physicians, Hagerstown — Hagerstown, Maryland (0.1 mi)
· Sponsor: Johns Hopkins University